Hillhouse Capital Advisors as of Dec. 31, 2019
Portfolio Holdings for Hillhouse Capital Advisors
Hillhouse Capital Advisors holds 54 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Iqiyi (IQ) | 12.3 | $986M | 47M | 21.11 | |
Beigene (BGNE) | 11.3 | $907M | 5.5M | 165.76 | |
Align Technology (ALGN) | 8.2 | $657M | 2.4M | 279.04 | |
TAL Education (TAL) | 6.9 | $553M | 12M | 48.20 | |
Zoom Video Communications In cl a (ZM) | 5.9 | $471M | 6.9M | 68.04 | |
Uber Technologies (UBER) | 5.7 | $461M | 16M | 29.74 | |
Jd (JD) | 5.2 | $419M | 12M | 35.23 | |
Alibaba Group Holding (BABA) | 5.2 | $420M | 2.0M | 212.10 | |
Enstar Group (ESGR) | 4.5 | $362M | 1.7M | 206.86 | |
Pinduoduo (PDD) | 4.1 | $330M | 8.7M | 37.82 | |
China Biologic Products | 4.0 | $320M | 2.8M | 116.38 | |
Bilibili Ads (BILI) | 2.4 | $190M | 10M | 18.62 | |
Sea Ltd Adr Isin Us81141r1005 (SE) | 2.1 | $173M | 4.3M | 40.22 | |
Fibrogen (FGEN) | 2.1 | $170M | 4.0M | 42.89 | |
Bridgebio Pharma (BBIO) | 1.9 | $154M | 4.4M | 35.05 | |
Apellis Pharmaceuticals (APLS) | 1.8 | $143M | 4.7M | 30.62 | |
Mondelez Int (MDLZ) | 1.8 | $140M | 2.5M | 55.08 | |
Viela Bio | 1.6 | $125M | 4.6M | 27.15 | |
Blueprint Medicines (BPMC) | 1.5 | $121M | 1.5M | 80.11 | |
Gossamer Bio (GOSS) | 1.1 | $92M | 5.9M | 15.63 | |
New Oriental Education & Tech | 0.9 | $73M | 603k | 121.25 | |
Snap Inc cl a (SNAP) | 0.9 | $73M | 4.5M | 16.33 | |
Myokardia | 0.9 | $71M | 976k | 72.89 | |
Nextcure (NXTC) | 0.7 | $59M | 1.1M | 56.33 | |
Line Corp- | 0.7 | $55M | 1.1M | 49.01 | |
Melco Crown Entertainment (MLCO) | 0.7 | $53M | 2.2M | 24.17 | |
Netflix (NFLX) | 0.6 | $44M | 136k | 323.57 | |
Bright Scholar Ed Hldgs | 0.4 | $35M | 4.0M | 8.83 | |
Arvinas Ord (ARVN) | 0.4 | $35M | 855k | 41.09 | |
Genmab A/s -sp (GMAB) | 0.4 | $34M | 1.5M | 22.33 | |
Zai Lab (ZLAB) | 0.4 | $33M | 798k | 41.59 | |
Smiledirectclub (SDCCQ) | 0.3 | $25M | 2.9M | 8.74 | |
G1 Therapeutics (GTHX) | 0.3 | $25M | 949k | 26.43 | |
Mogu Inc-adr spon ads | 0.3 | $24M | 10M | 2.28 | |
Kiniksa Pharmaceuticals (KNSA) | 0.3 | $21M | 1.9M | 11.06 | |
Akero Therapeutics (AKRO) | 0.2 | $20M | 891k | 22.19 | |
Regenxbio Inc equity us cm (RGNX) | 0.2 | $19M | 456k | 40.97 | |
Qualcomm (QCOM) | 0.2 | $18M | 200k | 88.23 | |
Uxin Ltd ads | 0.2 | $16M | 7.2M | 2.26 | |
Igm Biosciences (IGMS) | 0.2 | $13M | 350k | 38.16 | |
Hookipa Pharma Inc equity (HOOK) | 0.1 | $12M | 943k | 12.23 | |
Eidos Therapeutics | 0.1 | $10M | 179k | 57.39 | |
China Jo Jo Drugstores | 0.1 | $8.8M | 4.8M | 1.82 | |
Merus N V (MRUS) | 0.1 | $8.4M | 600k | 14.08 | |
Sohu (SOHU) | 0.1 | $9.0M | 802k | 11.18 | |
Argenx Se (ARGX) | 0.1 | $8.0M | 50k | 160.52 | |
Arcus Biosciences Incorporated (RCUS) | 0.1 | $7.7M | 767k | 10.10 | |
Affiliated Managers (AMG) | 0.1 | $6.0M | 71k | 84.74 | |
10x Genomics Inc Cl A (TXG) | 0.1 | $5.7M | 75k | 76.25 | |
Tcr2 Therapeutics Inc cs | 0.1 | $4.6M | 323k | 14.28 | |
Cellular Biomedicine Group I | 0.1 | $3.8M | 235k | 16.24 | |
Puxin Ltd ads | 0.0 | $1.0M | 126k | 8.20 | |
China Index Holdings | 0.0 | $1.1M | 300k | 3.64 | |
Fang Holdings | 0.0 | $858k | 300k | 2.86 |